TATAA Biocenter has partnered with Universal Sequencing Technology Corporation (UST) to offer full-service solutions for Long Read Sequencing Applications using UST TELL-Seq Linked Read technology. TATAA Biocenter was founded in 2001 and is a leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industries in Europe and to the Cell and […]

Veteran healthcare technology executive brings decades of operational experience applying advanced data analytics to enable the healthcare ecosystem MOUNTAIN VIEW, Calif. —  DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of healthcare and life science industry veteran Jovan Willford to its Board of […]

Combining expertise to advance precision medicine, while enabling efficient and timely insights into the diagnosis of rare diseases and hereditary cancer around the world SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass. & ROSTOCK, Germany & BERLIN — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon […]

Study will evaluate targeted sequencing-based testing for early detection of respiratory pathogens and emerging infectious diseases in airport wastewater samples RICHMOND, British Columbia — -Fusion Genomics announced today that the company has established a fully automated, first-of-its-kind infectious-disease surveillance facility at Toronto Pearson International Airport. The facility, which uses Fusion’s DNA sequencing-based ONETest platform, will […]

SAN FRANCISCO — Complete Genomics, Inc. (https://completegenomics.mgiamericas.com/), a subsidiary of MGI Tech Co., Ltd. (“MGI”), today unveiled its full sequencing platforms at Biotech Showcase during JP Morgan Healthcare Conference Week 2023. Rade Drmanac, PhD, Chief Scientific Officer, announced “free three-month trial” program and “reagent rental leasing” program, giving customers the opportunity to experience the quality and reliability of […]

FREDERICTON, CANADA – LuminUltra has partnered with the Greater Toronto Airports Authority (GTAA) to implement a cutting-edge, on-site laboratory to perform wastewater surveillance testing at Pearson International Airport. This pilot project, supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program, is using LuminUltra’s technology to test for the […]

First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice to analyse and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of […]

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence […]

Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong […]

MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a collaboration with the University of Tokyo, Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods in the hopes of better understanding the genetic causes of certain rare diseases in individuals and cohorts within the Japanese population. […]